Clinicians have been warned about the risk of death and severe harm arising from the incorrect use of injectable phenytoin.
A safety alert has today been issued about the drug, which is used to slow and stabilise erratic electrical brain activity, for example during epileptic seizures.
The alert, sent by NHS Improvement, said: “It is a particularly complicated drug to use and careful consideration must be given around prescribing, preparation, administration and monitoring.”
”The relatively high number of incidents caused by injectable phenytoin clearly shows the caution and precision required when using it”
Providers have been asked to consider if more can be done to strengthen local guidance, training and teamwork related to the use of injectable phenytoin, to reduce the risk of error.
This follows two recent fatal incidents involving the use of injectable phenytoin in status epilepticus.
New analysis by NHS Improvement of similar incidents in the past - which have resulted in severe and moderate harm and sometimes death - has revealed errors were often linked to factors including incorrect patient weight estimations, failure to take account of existing phenytoin levels, and stock not being available in the clinical area.
Other problems included misreading dosage amounts, confusion around dilution, the wrong diluent being used, and failure to use an in-line filter.
Mike Durkin, NHS national director for patient safety, said: “When patients come to hospital with an emergency such as a prolonged epileptic seizure, providing quick and extremely careful treatment is essential for their recovery.
“Staff across the NHS work hard handling challenging emergency situations on a daily basis, but we need to ensure harm from incorrect use of this medication is reduced.”
“Injectable phenytoin is an important medication for helping patients with epilepsy and other conditions, but the relatively high number of incidents caused by injectable phenytoin clearly shows the caution and precision required when using it,” he added.
By highlighting these incidents and the existing guidance on injectable phenytoin, it is hoped that hospitals can help their staff to give patients the safest and most effective care, he added.